Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) EBT Margin (2021)

Atea Pharmaceuticals has reported EBT Margin over the past 1 years, most recently at 63.08% for Q4 2021.

  • Quarterly results put EBT Margin at 63.08% for Q4 2021, changed N/A from a year ago — trailing twelve months through Sep 2022 was 18.75% (down 513.0% YoY), and the annual figure for FY2021 was 39.44%, up 6195.0%.
  • EBT Margin for Q4 2021 was 63.08% at Atea Pharmaceuticals, up from 67.34% in the prior quarter.
  • Over the last five years, EBT Margin for AVIR hit a ceiling of 63.08% in Q4 2021 and a floor of 67.34% in Q3 2021.